Nuvectis Pharma Inc. (NASDAQ: NVCT) Stock Information | RedChip

Nuvectis Pharma Inc. (NASDAQ: NVCT) Listen to this Section


$6.21
-0.0900 ( -1.43% ) 89.7K

Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.

Market Data


Open


$6.21

Previous close


$6.30

Volume


89.7K

Market cap


$117.14M

Day range


$6.11 - $6.61

52 week range


$5.85 - $15.50

Insider Ownership Transactions

Total Amount Purchased: 3,065.00 | $ 19,033.65

Date Type Amount Purchased Purchaser
2023-10-12 Buy 640.00 BENTSUR RON
2023-10-10 Buy 250.00 BENTSUR RON
2023-10-06 Buy 1820.00 BENTSUR RON
2023-08-16 Buy 235.00 BENTSUR RON
2023-08-11 Buy 120.00 BENTSUR RON

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 48 May 07, 2024
8-k 8K-related 15 May 07, 2024
def Proxies and info statements 6 Apr 29, 2024
4 Insider transactions 1 Mar 19, 2024
8-k 8K-related 16 Mar 05, 2024
10-k Annual reports 80 Mar 05, 2024
4 Insider transactions 1 Jan 05, 2024
4 Insider transactions 1 Jan 05, 2024
10-q Quarterly Reports 45 Nov 08, 2023
8-k 8K-related 14 Nov 08, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.